Literature DB >> 12845738

Study on the expression of Fas ligand on the surfaces of human cytotrophoblasts in normal pregnancy.

H Qiu1, Y Sun, L He.   

Abstract

To further study the mechanism of maternal-fetal immune tolerance, the expression of Fas ligand (FasL) on the surfaces of human cytotrophoblasts in normal pregnancy was detected by using immunohistochemical method. High precise color-image measure system for immuno-histochemistry was used to quantitatively analyze the expression of FasL. The results showed that FasL were expressed on the surfaces of placental cytotrophoblasts throughout normal pregnancy. The variance among the first, second and term pregnant stages was also detected. It was suggested that the expression of FasL on the surfaces of placental cytotrophoblasts might play an important role both in the maintenance of pregnancy and in the normal development of fetus. The maternal specific T cell apoptosis induced by Fas/FasL is one of the significant mechanisms of maternal-fetal immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12845738     DOI: 10.1007/bf02887063

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

1.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

2.  Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast.

Authors:  A King; C Boocock; A M Sharkey; L Gardner; A Beretta; A G Siccardi; Y W Loke
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

3.  Time course analysis of alpha+ beta+ T cell clones during normal pregnancy.

Authors:  T A Höger; M Tokuyama; K Yonamine; K Hayashi; K Masuko-Hongo; T Kato; T Kobata; Y Mizushima; K Nishioka; K Yamamoto
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

4.  Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft".

Authors:  S P Jiang; M S Vacchio
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

5.  A role for CD95 ligand in preventing graft rejection.

Authors:  D Bellgrau; D Gold; H Selawry; J Moore; A Franzusoff; R C Duke
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

Review 6.  Materno-fetal immunobiology in normal pregnancy and its possible failure in recurrent spontaneous abortion?

Authors:  G S Vince; P M Johnson
Journal:  Hum Reprod       Date:  1995-12       Impact factor: 6.918

Review 7.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.